Communication failures often create bigger risks than logistics disruptions. Learn why early visibility and escalation keep clinical supply chains on track.
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
- Building Stronger Sponsor–Vendor Relationships
- When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges
- July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
- Fast, Secure, And Defensible: Building Decisions That Can Be Challenged Internally And Defended Externally
- Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
From Frustration To Organization: An SSO Platform For Trial Sites
To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
Planning Your Packaging For A Seamless Transition From Clinic To Launch
Explore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
Clinical Supply Optimization: Process Improvement Accelerates Trials
A biopharmaceutical sponsor required the study start-up phase to be reduced to 91 days, involving comparator sourcing and blinding, kitting, packaging, labeling, and distribution to the sites.
-
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling
See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Risk Mitigation Planning For Pharmaceutical Tariffs
Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
-
The Dual Sourcing Approach
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
Precision and Compliance in Pharmaceutical Packaging
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Study, Not Software: Aligning RTSM To The Protocol
How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.